Katherine Unger Baillie

Improving HIV patients’ lives while they are on ART

HIV and AIDS drug regimens have vastly improved since the disease was first identified in the early 1980s. They have saved millions of lives, but they still have drawbacks. Up to half of all people living with HIV who are on antiretroviral therapies, or ART, have some sort of cognitive impairment, such as memory loss or reduced executive function.

Katherine Unger Baillie

Penn Science Café: ‘A Story of the Southern Ocean’

WHO:             Irina Marinov                         Assistant Professor

Katherine Unger Baillie, Gina Bryan

Penn Biologists Characterize New Form of mRNA Regulation

RNA, once thought to be a mere middleman between DNA and protein, is now recognized as the stage at which a host of regulatory processes can act to allow for flexibility in gene expression and thus the functions of cells and tissues.

Katherine Unger Baillie

Penn Vet researchers handicap Ebola and other dangerous viruses

Though the latest outbreak of Ebola appears to be nearing an end, the virus may pose a threat again in the future. Thus a drug to help individuals survive this dangerous infection, which has mortality rates up to 90 percent, is in intense demand.

Katherine Unger Baillie

PBS doc featuring Penn historian illuminates human cost of war

The cost of war is not limited to the price of tanks, training, and technology. In modern warfare, much of the expense accrues after the battles are completed, when injured troops come home and require ongoing, costly medical care. These post-war costs are not just financial, but moral.

Katherine Unger Baillie